These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26367865)

  • 21. Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: a double-blind randomized controlled trial.
    Pijpers JA; Kies DA; Louter MA; van Zwet EW; Ferrari MD; Terwindt GM
    Brain; 2019 May; 142(5):1203-1214. PubMed ID: 30982843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pilot study of amitriptyline in the prophylactic treatment of medication-overuse headache: a 1-year follow-up.
    Fan W; Lv Y; Ying G; Li W; Zhou J
    Pain Med; 2014 Oct; 15(10):1803-10. PubMed ID: 25159678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tapentadol prolonged release for managing moderate to severe, chronic malignant tumor-related pain.
    Kress HG; Koch ED; Kosturski H; Steup A; Karcher K; Lange B; Dogan C; Etropolski MS; Eerdekens M
    Pain Physician; 2014; 17(4):329-43. PubMed ID: 25054392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial.
    Schwartz S; Etropolski M; Shapiro DY; Okamoto A; Lange R; Haeussler J; Rauschkolb C
    Curr Med Res Opin; 2011 Jan; 27(1):151-62. PubMed ID: 21162697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: a Phase III, multicenter, randomized, double-blind, placebo-controlled study conducted over 5 days.
    Riff DS; Duckor S; Gottlieb I; Diamond E; Soulier S; Raymond G; Boesing SE
    Clin Ther; 2009 Oct; 31(10):2072-85. PubMed ID: 19922878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of 3 Treatment Strategies for Medication Overuse Headache: A Randomized Clinical Trial.
    Carlsen LN; Munksgaard SB; Nielsen M; Engelstoft IMS; Westergaard ML; Bendtsen L; Jensen RH
    JAMA Neurol; 2020 Sep; 77(9):1069-1078. PubMed ID: 32453406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biofeedback in the prophylactic treatment of medication overuse headache: a pilot randomized controlled trial.
    Rausa M; Palomba D; Cevoli S; Lazzerini L; Sancisi E; Cortelli P; Pierangeli G
    J Headache Pain; 2016 Dec; 17(1):87. PubMed ID: 27655371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study.
    Cowan RP; Marmura MJ; Diener HC; Starling AJ; Schim J; Hirman J; Brevig T; Cady R
    J Headache Pain; 2022 Sep; 23(1):115. PubMed ID: 36068494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized controlled trial on medication-overuse headache: outcome after 1 and 4 years.
    Hagen K; Stovner LJ
    Acta Neurol Scand Suppl; 2011; (191):38-43. PubMed ID: 21711255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practical management of medication-overuse headache.
    Paemeleire K; Crevits L; Goadsby PJ; Kaube H
    Acta Neurol Belg; 2006 Jun; 106(2):43-51. PubMed ID: 16898253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
    Peniston JH; Gould E
    Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral dependence in patients with medication overuse headache: a cross-sectional study in consulting patients using the DSM-IV criteria.
    Radat F; Creac'h C; Guegan-Massardier E; Mick G; Guy N; Fabre N; Giraud P; Nachit-Ouinekh F; Lantéri-Minet M
    Headache; 2008 Jul; 48(7):1026-36. PubMed ID: 18081820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sodium valproate in migraine without aura and medication overuse headache: a randomized controlled trial.
    Sarchielli P; Messina P; Cupini LM; Tedeschi G; Di Piero V; Livrea P; Pini LA; Bernardi G; Bono G; Sandrini G; Caproni S; Corbelli I; Pisani F; Beghi E; Calabresi P;
    Eur Neuropsychopharmacol; 2014 Aug; 24(8):1289-97. PubMed ID: 24862255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medication-Overuse Headache: Protocols and Outcomes in 149 Consecutive Patients in a Tertiary Brazilian Headache Center.
    Krymchantowski AV; Tepper SJ; Jevoux C; Valença M
    Headache; 2017 Jan; 57(1):87-96. PubMed ID: 27861826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study protocol: brief intervention for medication overuse headache--a double-blinded cluster randomised parallel controlled trial in primary care.
    Kristoffersen ES; Straand J; Benth JS; Russell MB; Lundqvist C
    BMC Neurol; 2012 Aug; 12():70. PubMed ID: 22883540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severity of Analgesic Dependence and Medication-overuse Headache.
    Lundqvist C; Gossop M; Russell MB; Straand J; Kristoffersen ES
    J Addict Med; 2019; 13(5):346-353. PubMed ID: 30724760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of successful primary care detoxification treatment for medication-overuse headache.
    Kristoffersen ES; Straand J; Benth JŠ; Russell MB; Lundqvist C
    Acta Neurol Scand; 2017 Nov; 136(5):486-494. PubMed ID: 28369734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.